- Home
- / Zhejiang Shengda Bio-Pharm
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zhejiang Shengda Bio-Pharm financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥14.4
2024-10-29
Market Capitalization
¥2.3 B
2024-10-29
Revenue
¥829.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 484.6M | 511.5M | 848.0M | 777.5M | 728.3M | 716.0M | 815.5M | 829.7M |
| Cost of goods sold | 327.4M | 326.6M | 393.7M | 561.3M | 607.2M | 611.0M | 651.5M | 623.7M |
| Gross profit | 157.6M | 186.5M | 461.3M | 217.4M | 122.2M | 107.0M | 164.8M | 209.9M |
| Gross profit margin, % | 36.5% | 54.4% | 28.0% | 16.8% | 14.9% | 20.2% | 25.3% | |
| Operating expense total | 70.2M | 73.1M | 117.1M | 78.6M | 46.2M | 47.0M | 48.2M | 57.9M |
| Depreciation and amortization | 33.0M | 51.7M | 69.7M | 70.9M | 67.7M | 82.7M | 74.1M | 76.5M |
| EBITDA | 87.3M | 113.4M | 344.2M | 138.8M | 76.0M | 60.0M | 116.7M | 151.9M |
| EBITDA margin, % | 22.2% | 40.6% | 17.9% | 10.4% | 8.4% | 14.3% | 18.3% | |
| EBIT | 49.1M | 53.0M | 244.8M | 67.4M | 3.4M | (56.2M) | 38.6M | 73.2M |
| EBIT margin, % | 10.4% | 28.9% | 8.7% | 0.5% | -7.8% | 4.7% | 8.8% | |
| Interest income | 2.7M | 4.3M | 4.2M | 2.9M | 4.0M | 8.4M | 8.0M | 8.5M |
| Interest expense | 6.2M | 11.1M | 4.6M | 5.8M | 4.6M | 1.5M | 2.1M | 909.0K |
| Pre tax profit | 52.4M | 49.2M | 223.7M | 80.0M | 36.5M | (45.3M) | 49.1M | 80.1M |
| Income tax expense | 9.8M | 11.4M | 33.7M | 8.2M | 6.1M | 8.9M | 11.8M | 10.9M |
| Net Income | 42.6M | 37.8M | 190.0M | 71.8M | 30.4M | (54.2M) | 37.3M | 69.3M |